Advertisement
New Zealand markets closed
  • NZX 50

    11,719.82
    +29.57 (+0.25%)
     
  • NZD/USD

    0.6202
    +0.0007 (+0.12%)
     
  • NZD/EUR

    0.5725
    +0.0008 (+0.13%)
     
  • ALL ORDS

    7,899.20
    +33.90 (+0.43%)
     
  • ASX 200

    7,643.60
    +32.40 (+0.43%)
     
  • OIL

    78.04
    -0.57 (-0.73%)
     
  • GOLD

    2,030.60
    -0.10 (-0.00%)
     
  • NASDAQ

    18,004.70
    +525.80 (+3.01%)
     
  • FTSE

    7,684.49
    +21.98 (+0.29%)
     
  • Dow Jones

    39,069.11
    +456.87 (+1.18%)
     
  • DAX

    17,370.45
    +252.35 (+1.47%)
     
  • Hang Seng

    16,734.59
    -8.36 (-0.05%)
     
  • NIKKEI 225

    39,098.68
    +836.48 (+2.19%)
     
  • NZD/JPY

    93.3320
    +0.1320 (+0.14%)
     

The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?

The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?

It's a no-brainer to invest in businesses that are making headway in the growth markets of the future. In biopharma, therapies to treat or prevent Alzheimer's disease constitute one such growth market. Let's survey the competitive landscape as it is today, and think through how it's likely to develop.